RELUGOLIX COMBINATION THERAPY IN NORTH AMERICAN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: SPIRIT 1 AND 2 TRIALS

In: Fertility and Sterility · 2022 · vol. 118(4) , pp. e223 · doi:10.1016/j.fertnstert.2022.08.633 · W4307392921
article OA: closed CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

Relugolix combination therapy significantly reduced endometriosis-associated pain in North American women participating in the SPIRIT 1 and 2 trials.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK